According to our (Global Info Research) latest study, the global Blockchain In Pharmaceutical market size was valued at US$ 4802 million in 2024 and is forecast to a readjusted size of USD 94680 million by 2031 with a CAGR of 53.7% during review period.
Blockchain In Pharmaceutical refers to the application of blockchain technology in the healthcare field. It allows personal health information to be stored in the network, enabling healthcare providers to have broader access to patients' basic health information while securely storing this information through encrypted signatures.
Among the different types of blockchain in pharmaceutical, the private blockchain held the maximum market share with about 91%. For applications of the blockchain in pharmaceutical, the supply chain logistics is the largest segment with a market share of nearly 69%.
Market Drivers
1. Supply Chain Transparency and Traceability
Blockchain provides an immutable and decentralized ledger that enables end-to-end visibility across the pharmaceutical supply chain. This helps combat counterfeit drugs, track the movement of raw materials and finished products, and ensure authenticity, which is critical for patient safety.
2. Counterfeit Drug Prevention
Counterfeit drugs pose a significant threat to global health, costing the industry billions annually. Blockchain’s ability to create tamper-proof records ensures that every drug can be traced back to its origin, reducing the risk of counterfeit products entering the market.
3. Regulatory Compliance
Pharmaceutical companies face stringent regulations from agencies like the FDA and EMA. Blockchain simplifies compliance by providing a transparent and auditable record of every transaction, from manufacturing to distribution, ensuring adherence to regulatory requirements.
4. Improved Drug Recall Management
In the event of a drug recall, blockchain enables rapid identification of affected batches and their distribution channels. This minimizes the impact on patients and reduces financial losses for manufacturers.
5. Enhanced Data Security and Privacy
Blockchain’s cryptographic algorithms ensure secure storage and sharing of sensitive data, such as patient records and clinical trial data. This is particularly important in an era of increasing cyber threats and data breaches.
This report is a detailed and comprehensive analysis for global Blockchain In Pharmaceutical market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Blockchain In Pharmaceutical market size and forecasts, in consumption value ($ Million), 2020-2031
Global Blockchain In Pharmaceutical market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Blockchain In Pharmaceutical market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Blockchain In Pharmaceutical market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Blockchain In Pharmaceutical
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Blockchain In Pharmaceutical market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include IBM, AWS, Microsoft, SAP, Chronicled, Embleema, FarmaTrust, Guardtime Federal, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Blockchain In Pharmaceutical market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Private Blockchain
Hybrid Blockchain
Market segment by Application
Supply Chain Logistics
Drug Safety
Clinical Trial Management
IOMT & Cyber Security
Market segment by players, this report covers
IBM
AWS
Microsoft
SAP
Chronicled
Embleema
FarmaTrust
Guardtime Federal
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Blockchain In Pharmaceutical product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Blockchain In Pharmaceutical, with revenue, gross margin, and global market share of Blockchain In Pharmaceutical from 2020 to 2025.
Chapter 3, the Blockchain In Pharmaceutical competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Blockchain In Pharmaceutical market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Blockchain In Pharmaceutical.
Chapter 13, to describe Blockchain In Pharmaceutical research findings and conclusion.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook